Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Inderjote Kathuria M.B.A., M.D. | Chief Strategy Officer | -- | -- | 1967 |
| Dr. Chirinjeev Baboo Kathuria M.B.A., M.D. | Founder & Executive Chairman of the Board | -- | -- | 1965 |
| Dr. M. Michelle Berrey M.D., M.P.H. | Interim CEO & Director | -- | -- | 1967 |
| Dr. Jack A. Elias M.D. | Founder, Chairman of Scientific Advisory Board & Independent Director | -- | -- | 1951 |
| Dr. Jonathan Kurtis M.D., Ph.D. | Founder, Chairman of Scientific Advisory Board & Director | -- | -- | 1968 |
| Ms. Jolie G. Kahn CPA, Esq. | Chief Financial Officer | -- | -- | 1965 |
| Mr. Robert John Sweeney | Chief Accounting Officer & Assistant Secretary | -- | -- | 1965 |
Ocean Biomedical, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.
Corporate Governance
Upcoming Events
December 23, 2024 at 1:30 PM UTC
Ocean Biomedical, Inc. Earnings Date
Recent Events
Recent Events Information Not Available